Cite
MLA Citation
Jürg Bernhard et al.. “Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.” Lancet oncology, vol. 16, no. 7, n.d., pp. 848–858. http://access.bl.uk/ark:/81055/vdc_100025942483.0x000049